Submit dental news and dentistry-related press releases, along with images (for which you own the copyright), to media@dentalblogs.com. We will review your submission. Not all submissions will be posted or covered in an article. However, all submissions are appreciated.
A new independent, international dental journal, Dental Hypotheses, will soon hit the web and the press. Like many dentistry publications, this journal will provide peer-reviewed articles for the professional dental community. However, Editors-In-Chief Edward F. Rossomando (Director of the Biodontics® Program at the University of Connecticut School of Dental Medicine., United States) and Jafar Kolahi (Torabinejad Research Center, Isfahan University of Medical Sciences,Isfahan, Iran, Islamic Republic)and their editorial team seek submissions about controversial and out-of-the-ordinary issues. For example, nano-dentistry, biodontics, dental specialties, community dental health, and the economy of dentistry are ideal topics for submission.
Dental Hypotheses is not supported by any institution, commercial company, or advertisers, and authors are not charged for publication. The magazine supports academic freedom for presentation and criticism of challenging, thought-provoking ideas in the dental field. Expect to see radical, speculative and non-mainstream concepts in the pages of this journal.
If you’d like to submit an article for review, see guidelines here. You can also read about the peer review process at www.dentalhypotheses.com. Articles are accepted by online submission.
Easily and Precisely Reconstructs Natural Occlusion
Automatic Design Procedure is Fast, Reliable, and Compatible with all Restorative Indications
Charlotte, NC (February 25, 2010) – Sirona Dental Systems, LLC (Nasdaq: SIRO), the company that pioneered digital impressions and dental CAD/CAM 25 years ago and the world’s leading producer of dental CAD/CAM and digital impression systems, is pleased to introduce user-friendly software developed for its CEREC® chairside system. The new software is based on Sirona’s patented Biogeneric technology. [Read more →]
Release 3 Brings Accelerated Performance, More Types of Fixed and Removable Prosthetics, Support for Milling, Impression Scanning and More
WOBURN, Massachusetts – February 25, 2010 - SensAble Technologies, Inc®, a leading provider of touch-enabled 3D modeling systems, dental CAD/CAM solutions and haptic devices, has announced Release 3 of the SensAble Dental Lab System (SDLS), with significant enhancements to this integrated system for creating dental restorations efficiently and more cost-effectively.
Release 3 dramatically speeds the scan, design and fabrication processes for partial dentures as well as crowns and bridges; provides support for milling; adds support for impression scanning and the SensAble OpenScan™ interface; and expands SensAble’s unique software intelligence, called Intelli-Fit™, that automatically compensates for inaccuracies inherent in both digital and manual processes such as scanning artifacts and physical distortions introduced during fabrication processes. With analysts predicting a significant increase in CAD/CAM-created dental prosthetic devices through 2015¹ , Release 3 lets labs gain optimal value from their technology investment and achieve sought-after efficiencies throughout their workflow. [Read more →]
Researchers at Howard University in Washington College of Dentistry believe that tooth enamel stores important data about a person’s exposure to radiation. The team is developing Electron Paramagnetic Resonance (EPR) to determine the level of free radicals in substances, including tooth enamel.
What will this information be used for? The hope is that EPR can assist medical workers in triaging patients or dividing victims of radiation exposure into classes by the amount of radiation received. The new technology is minimally-invasive and would provide data useful in treating people exposed to radiation in an accident or by a “dirty bomb,” which refers to a radiation dispersal device. [Read more →]
Dentalblogs has covered OraVerse in previous posts. The drug is intended to reverse the effects of local anesthesia quickly so that patients promptly regain feeling in areas made numb during dental procedures.
On February 26th, xconomy San Diego published an article that tells us the FDA is not pleased with a marketing brochure published by Novalar. The FDA instructed Novalar, maker of OraVerse, to amend the drug brochure. Read the letter here. The FDA claims that the brochure minimizes and omits risks and overstates benefits of OraVerse. Issues such as pain at the injection site, headache, and pain following a dental procedure are not mentioned in the brochure. In addition, the brochure states that OraVerse can be administered to children as young as four years old, while it is actually cleared for children six and older.
The Novalar CEO, Donna Jansen, says that the brochure in question is no longer in use. If you’re concerned that you may still have copies of the brochure in question, visit xconomy to download a PDF.